3 research outputs found

    Avaliação técnico-econômica de suínos machos imuno e cirurgicamente castrados

    Get PDF
    Realizou-se este estudo com o objetivo de avaliar o desempenho técnico-econômico e determinar a lucratividade, por meio da análise de sensibilidade econômica, de suínos machos imuno (IM) e cirurgicamente castrados (MC). Foram realizados dois experimentos, em delineamento inteiramente casualizado, composto por dois tratamentos (IM e MC), com oito repetições de 10 animais cada, totalizando 160 suínos por experimento. Verificou-se que suínos IM apresentam menor consumo de ração e melhor conversão alimentar nas fases de crescimento em relação aos MC. Na fase de terminação, suínos IM apresentam melhor ganho de peso, conversão alimentar, rendimento de carcaça e porcentagem de carne em relação aos MC. A utilização de IM aumenta a lucratividade na produção de suínos. A análise de lucratividade entre suínos IM e MC deve considerar todas as fases de criação, uma vez que o desempenho diferencial dos suínos não castrados na fase de crescimento influencia economicamente os resultados da produção.This study was conducted to evaluate the technical and economic performance and determine profitability through the economic sensitivity analysis of immune (IM) and male pigs surgically castrated (SC). Two experiments were conducted in a completely randomized design, consisting of two treatments (IM and SC) with eight replicates of 10 animals each, totaling 160 pigs per experiment. It was found that IM pigs have lower feed intake and feed conversion during the growth phases in relation to SC. In the finishing phases, IM have better weight gain, feed conversion, carcass yield and lean meat percentage in relation to SC. The use of IM increases the profitability in pig production. The analysis of profitability differential between IM and SC should consider all stages of creation, since the differential performance of not castrated pigs during growth influences economic results of production

    Evolution over Time of Ventilatory Management and Outcome of Patients with Neurologic Disease∗

    No full text
    OBJECTIVES: To describe the changes in ventilator management over time in patients with neurologic disease at ICU admission and to estimate factors associated with 28-day hospital mortality. DESIGN: Secondary analysis of three prospective, observational, multicenter studies. SETTING: Cohort studies conducted in 2004, 2010, and 2016. PATIENTS: Adult patients who received mechanical ventilation for more than 12 hours. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Among the 20,929 patients enrolled, we included 4,152 (20%) mechanically ventilated patients due to different neurologic diseases. Hemorrhagic stroke and brain trauma were the most common pathologies associated with the need for mechanical ventilation. Although volume-cycled ventilation remained the preferred ventilation mode, there was a significant (p < 0.001) increment in the use of pressure support ventilation. The proportion of patients receiving a protective lung ventilation strategy was increased over time: 47% in 2004, 63% in 2010, and 65% in 2016 (p < 0.001), as well as the duration of protective ventilation strategies: 406 days per 1,000 mechanical ventilation days in 2004, 523 days per 1,000 mechanical ventilation days in 2010, and 585 days per 1,000 mechanical ventilation days in 2016 (p < 0.001). There were no differences in the length of stay in the ICU, mortality in the ICU, and mortality in hospital from 2004 to 2016. Independent risk factors for 28-day mortality were age greater than 75 years, Simplified Acute Physiology Score II greater than 50, the occurrence of organ dysfunction within first 48 hours after brain injury, and specific neurologic diseases such as hemorrhagic stroke, ischemic stroke, and brain trauma. CONCLUSIONS: More lung-protective ventilatory strategies have been implemented over years in neurologic patients with no effect on pulmonary complications or on survival. We found several prognostic factors on mortality such as advanced age, the severity of the disease, organ dysfunctions, and the etiology of neurologic disease
    corecore